The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician’s choice systemic therapy in patients with breast cancer brain metastases.
 
Colette Shen
Consulting or Advisory Role - GT Medical Technologies; Nanobiotix
Research Funding - AstraZeneca/MedImmune
Patents, Royalties, Other Intellectual Property - In Vitro Microphysiological System For High Throughput 3D Tissue Organization And Biological Function, patent issued 12/06/16 --no royalties (I); Microscopy with Lattice Light Sheets and Point Accumulation for Imaging and Nanoscale Topography, patent filed 12/7/15 --no royalties (I)
Travel, Accommodations, Expenses - Nanobiotix
 
Yara Abdou
Honoraria - Clinical Care Options; MJH Associates; WebMD/Medscape
Consulting or Advisory Role - AstraZeneca; Exact Sciences
Research Funding - Carisma Therapeutics (Inst)
Travel, Accommodations, Expenses - Carisma Therapeutics
 
Linda Chen
No Relationships to Disclose
 
Xianming Tan
No Relationships to Disclose
 
Gaorav P. Gupta
Stock and Other Ownership Interests - Naveris
Consulting or Advisory Role - Naveris
Research Funding - Breakpoint Therapeutics (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Patent related to circulating HPV DNA detection technology (Inst)
 
Filipa Lynce
Consulting or Advisory Role - AmerisourceBergen; AstraZeneca; Daiichi Sankyo/Astra Zeneca; OncoSec; Pfizer; Prime Education
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Bristol-Myers Squibb; CytomX Therapeutics (Inst); Immunomedics (Inst); Inivata (Inst)
 
Mina Lobbous
No Relationships to Disclose
 
Erica Michelle Stringer-Reasor
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Lilly; Merck; Merck; Novartis; OncoSec; Seagen
Research Funding - Susan G. Komen for the Cure; V Foundation
 
Carey K. Anders
Honoraria - AstraZeneca; Athenex; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; IPSEN; Novartis; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca; Athenex; Eisai; Elucida Oncology; Genentech/Roche; Immunomedics; Ipsen; Seagen
Research Funding - AstraZeneca (Inst); Caris Life Sciences (Inst); Elucida Oncology (Inst); G1 Therapeutics (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst); Tesaro (Inst); Zion Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlett; Up to Date.com
Travel, Accommodations, Expenses - Eisai